Solid Biosciences (SLDB) Reports Q1 Loss of $0.61/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts SLDB Hot Sheet
Join SI Premium – FREE
Solid Biosciences (NASDAQ: SLDB) reported Q1 EPS of ($0.61), versus ($1.25) reported last year.
For earnings history and earnings-related data on Solid Biosciences (SLDB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- Livanova (LIVN) PT Raised to $120 at Jefferies
- Marriott International (MAR) PT Lowered to $141 at Jefferies
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
